Know Cancer

or
forgot password

Characterization of Liver Masses With Contrast Enhanced Ultrasound (CEUS): A Comparison With Standard Institutional Contrast Enhanced CT (CECT) or MR Scan (CEMRI)


N/A
18 Years
90 Years
Open (Enrolling)
Both
Liver Tumors

Thank you

Trial Information

Characterization of Liver Masses With Contrast Enhanced Ultrasound (CEUS): A Comparison With Standard Institutional Contrast Enhanced CT (CECT) or MR Scan (CEMRI)


Inclusion Criteria:



- An incidental liver mass amenable to US evaluation

- Undiagnosed liver mass

- Mass threshold size is 2.5 cm

- Source of subjects:

- Liver mass found on conventional institutional US

- Liver mass detected on CT and MRI that remain uncategorized

- Referral of patient with a liver mass following detection in outside
institution.

- Confirmatory CT or MRI performed within 60 days of initial scan according to the
institutional protocols

Exclusion Criteria:

- Any known pre existing mass

- Pregnancy

- Severe or unstable cardiac disease, including angina, congestive heart failure, or
arrhythmias

- Severe COPD

- Pulmonary hypertension

- Bidirectional shunts

- Transient right to left shunts

- Known hypersensitivity to Definity or any of its components

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Malignancy of the liver mass, as determined on US, on CEUS, and on CECT or CEMRI.

Outcome Time Frame:

6-9 months

Safety Issue:

No

Principal Investigator

Stephanie R Wilson, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Foothills Medical Centre

Authority:

Canada: Health Canada

Study ID:

(Ethics ID: 21295)

NCT ID:

NCT00828607

Start Date:

January 2009

Completion Date:

December 2012

Related Keywords:

  • Liver Tumors
  • Contrast Enhanced Ultrasound (CEUS)
  • Liver tumors
  • Hepatocellular carcinoma
  • Hemangioma
  • Focal Nodular Hyperplasia
  • Hepatic metastases
  • Liver Neoplasms

Name

Location